Newsroom | 10135 results

Sorted by: Latest

Cardiology
-

DiaMedica Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (“DiaMedica” or the “Company”) (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia (PE), fetal growth restriction (FGR) and acute ischemic stroke (AIS), today provided a business update and reported financial results for the third quarter ended September 30, 2026. Management will host a conference call Friday, November 13, 2026, at 8:00 AM Eastern Time / 7:00 AM Central Time...
-

HeartBeam Reports Third Quarter 2026 Results

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Third Quarter 2026 Results...
-

Arrowhead Pharmaceuticals Reports 2026 Fiscal Year-End Results

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its 2026 fiscal year ended September 30, 2026. The Company is hosting a conference call today, November 12, 2026, at 4:30 p.m. ET to discuss the results. “Arrowhead has fundamentally changed over the past 12 months. Where there was once a company that relied solely on great scientific promise, there is now a company that is beginning to translate promise into real patient outc...
-

Rocket Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Recent Progress

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing genetic medicines for rare and life-threatening diseases, with a strategic focus on inherited cardiovascular disorders, today reported financial results for the third quarter ended September 30, 2026, and provided recent business updates. “With FDA alignment on the pivotal RP-A501 trial in Danon disease, our priority is to complete dosing by mid-2027...
-

Plexus Worldwide® Raises $165,384 for Phoenix Children’s Center at Ninth Annual Pima Center Community Walk

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Plexus Worldwide gathered more than 750 participants from local businesses and the community for its ninth annual Pima Center Community Walk, contributing $165,384 for Phoenix Children’s Center for Heart Care. Held at the company’s Scottsdale headquarters, the event brought together employees, neighboring businesses, families and friends to support children with heart conditions in receiving specialized, compassionate care. All proceeds from the event will be...
-

Hello Heart Takes On the High Cost of Heart Failure With Hello Guard

MENLO PARK, Calif.--(BUSINESS WIRE)--Hello Heart, the leader in AI-powered preventive heart health, today introduced Hello Guard, a new heart failure offering with a clear ambition: help people get support before a crisis and reduce avoidable hospitalizations that drive substantial costs for health plans. For someone living with heart failure, a shift in weight or a new symptom can raise an urgent question: Can this wait until the next appointment? Hello Guard brings connected devices, personal...
-

Virta Health Reduces Risk of Heart Attack, Stroke, and Death by 56%

DENVER--(BUSINESS WIRE)--Virta Health, the leader in reversing metabolic disease, today announced new peer-reviewed research published in Cardiology and Therapy which shows members following Virta’s individualized nutrition therapy and AI-powered, continuous clinical care had a 56% lower risk of major cardiovascular events, including heart attack, stroke and death, than those receiving standard care. These results are independent of the use of medications, such as GLP-1s. Cardiovascular disease...
-

Cardio Diagnostics’ Whitepaper Examines Clinical Blind Spot in Coronary Heart Disease Detection and Care

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics released a new whitepaper as a resource for clinicians navigating current limitations in detecting and managing NOCAD....
-

Kardigan Reports Third Quarter 2026 Financial Results and Recent Business Updates

SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)--Kardigan today reported financial results for the third quarter ended September 30, 2026, and provided recent business updates....
-

Mammoth Biosciences Advances Lead Candidate MB-111 Toward the Clinic with the Presentation of Preclinical Durability and Safety Data at American Heart Association Scientific Sessions 2026

BRISBANE, Calif.--(BUSINESS WIRE)--Durable efficacy and favorable safety profile supports planned 2027 clinical testing in persistent chylomicronemia....